Genomics Personalized Health Market Report 2026

Genomics Personalized Health Market Overview

• Genomics Personalized Health market size has reached to $18.5 billion in 2025 • Expected to grow to $36.55 billion in 2030 at a compound annual growth rate (CAGR) of 14.2% • Growth Driver: Rising Demand For Personalized Medicine Drives Growth In Genomics Personalized Health Market • Market Trend: Advancements In Next-Generation Sequencing (NGS) To Offer Broad Applications • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Genomics Personalized Health Market?

Genomics personalized health refers to using genomic information to tailor medical care and interventions to individual patients, considering their unique genetic makeup, lifestyle factors, and environmental influences. This approach leverages advancements in genomics, bioinformatics, and personalized medicine to provide more precise and effective healthcare solutions tailored to each individual's genetic predispositions, risk factors, and treatment responses. The main test types of genomics personalized health included are oncology testing, infectious disease testing, orphan disease testing, autoimmune disease testing, obstetrics testing, and others. Oncology testing involves using genetic tests to detect cancer and understand its specific characteristics. It includes technology such as NGS platforms, RT-PCR, microarray, and genetic analyzers. It is provided to end users such as academic research institutes, diagnostic centers, and others.

What Is The Genomics Personalized Health Market Growth Forecast?

The genomics personalized health market size is expected to see rapid growth in the next few years. It will grow to $36.55 billion in 2030 at a compound annual growth rate (CAGR) of 14.2%. The growth in the forecast period can be attributed to increasing adoption of population-scale genomics programs, rising investments in AI-driven diagnostics, expansion of personalized therapeutics, growing integration of genomics in routine clinical care, increasing focus on predictive healthcare models. Major trends in the forecast period include increasing adoption of genomic data analytics platforms, rising use of AI for variant interpretation, expansion of personalized treatment pathways, growing integration of genomics in preventive healthcare, enhanced focus on precision diagnostics.

Global Genomics Personalized Health Market Segmentation

1) By Test Type: Oncology Testing, Infectious Disease Testing, Orphan Disease Testing, Autoimmune Disease Testing, Obstetrics Testing 2) By Technology: NGS Platforms, Microarray, Genetic Analyzers 3) By End User: Academic Research Institutes, Diagnostic Centers, Other End Users Subsegments: 1) By Oncology Testing: Cancer Genomic Profiling, Liquid Biopsy Testing, Tumor Mutational Burden Testing, Genetic Biomarker Testing 2) By Infectious Disease Testing: Next-Generation Sequencing (NGS) Tests, Microbial Genomic Profiling 3) By Orphan Disease Testing: Genetic Screening For Rare Diseases, Genetic Testing For Inherited Disorders, Targeted Gene Panels 4) By Autoimmune Disease Testing: Genetic Screening For Autoimmune Conditions, Immune System Gene Profiling, HLA Typing Tests 5) By Obstetrics Testing: Non-Invasive Prenatal Testing (NIPT), Genetic Screening For Birth Defects, Carrier Screening Tests

What Is The Driver Of The Genomics Personalized Health Market?

The growing demand for personalized medicine is expected to propel the growth of the genomics personalized health market going forward. Personalized medicine, also known as precision medicine, is an approach to healthcare that tailors medical treatment and practices to the individual characteristics of each patient. The demand for personalized medicine is due to a shift toward preventive healthcare, improved treatment outcomes, patient empowerment and engagement, economic benefits, and rising incidence of chronic and complex diseases. Genomics personalized health significantly advances personalized medicine by leveraging individual genetic information to tailor medical care, from prevention and diagnosis to treatment and monitoring. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, the Food and Drug Administration (FDA) approved 16 novel personalized therapies for patients with rare diseases in 2023, compared to six in 2022. Therefore, the growing demand for personalized medicine is driving the demand for genomics personalized health industry.

Key Players In The Global Genomics Personalized Health Market

Major companies operating in the genomics personalized health market are Illumina Inc., Quest Diagnostics, Exact Sciences Corporation, Natera Inc., Adaptive Biotechnologies Corporation, Myriad Genetics Inc., Pacific Biosciences of California Inc., Personalis Inc., Invitae Corporation, GRAIL Inc., XCode Life Sciences Private Limited, BGI Genomics Co. Ltd., Genetic Technologies Limited, Eastern Biotech and Life Sciences, Tempus AI, Guardant Health, Freenome, Color Genomics, Helix, NantOmics, Novogenia GmbH, Clear Labs

Global Genomics Personalized Health Market Trends and Insights

Major companies operating in the genomics personalized health market are focused on developing innovative products, such as for cloud-based software designed for tertiary analysis of clinical next-generation sequencing (NGS) data., to gain a competitive edge in the market. Clinical next-generation sequencing (NGS) data refers to the genetic information generated from sequencing technologies that allow for high-throughput, detailed analysis of DNA or RNA samples in a clinical setting. For instance, in March 2023, Illumina, a US-based biotechnology company specializing in DNA sequencing and array-based technologies, launched Connected Insights, a cloud-based software designed for tertiary analysis of clinical next-generation sequencing (NGS) data. This platform aims to streamline the interpretation and reporting processes, particularly for oncology applications, and supports comprehensive genomic profiling. Connected Insights integrates various third-party knowledge bases, facilitating precise data analysis and enhancing the efficiency of precision care initiatives

What Are Latest Mergers And Acquisitions In The Genomics Personalized Health Market?

In January 2023, Agilent Technologies Inc., a US-based life sciences and analytical instrumentation company, acquired Avida Biomed Inc. for US$30 million. With this acquisition, Agilent aims to enhance its next‑generation sequencing (NGS) capabilities and expand into the high‑growth clinical research and diagnostics markets. Avida Biomed, Inc. is a US-based biotechnology company specializing in genomics and personalized health.

Regional Insights

North America was the largest region in the personalized health market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Genomics Personalized Health Market?

The genomics personalized health market consists of revenues earned by entities by providing services such as genetic testing, genomic sequencing, bioinformatics analysis, and consulting services. The market value includes the value of related goods sold by the service provider or included within the service offering. The genomics personalized health market also includes sales of genomic data management solutions, DNA sequencing kits, personalized wellness and nutrition products, pharmacogenomics tests, and companion diagnostics. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Genomics Personalized Health Market Report 2026?

The genomics personalized health market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the genomics personalized health industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.